Insulin secretion in diabetes mellitus.
暂无分享,去创建一个
[1] J. Halter,et al. Potentiation of Insulin Secretion to Nonglucose Stimuli in Normal Man by Tolbutamide , 1980, Diabetes.
[2] C. J. Hedeskov. Mechanism of glucose-induced insulin secretion. , 1980, Physiological reviews.
[3] L. Regeur,et al. Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. , 1979, British medical journal.
[4] R. Robertson. Prostaglandins as modulators of pancreatic islet function. , 1979, Diabetes.
[5] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[6] J. Halter,et al. Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. , 1979, The Journal of clinical endocrinology and metabolism.
[7] J. Halter,et al. Paradoxical inhibition of insulin secretion by glucose in human diabetes mellitus. , 1979, The Journal of clinical endocrinology and metabolism.
[8] R. Holman,et al. Maintenance of Basal Plasma Glucose and Insulin Concentrations in Maturity-Onset Diabetes , 1979, Diabetes.
[9] G. Weir,et al. Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. , 1979, The Journal of clinical investigation.
[10] R. Robertson,et al. Sounding board. Prostaglandins, the glucoreceptor, and diabetes. , 1979, The New England journal of medicine.
[11] G. Sartor,et al. Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. , 2009, Acta medica Scandinavica.
[12] R. Robertson,et al. Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dog. , 1978, The Journal of clinical investigation.
[13] J. Holst,et al. Secretory effects of VIP on isolated perfused porcine pancreas. , 1978, The American journal of physiology.
[14] J. Halter,et al. Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin. , 1978, The Journal of clinical endocrinology and metabolism.
[15] L Orci,et al. Insulin, glucagon, and somatostatin secretion in the regulation of metabolism. , 1978, Annual review of physiology.
[16] G. Grodsky,et al. Pancreatic action of the sulfonylureas. , 1977, Federation proceedings.
[17] R. Unger,et al. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. , 1977, The Journal of clinical investigation.
[18] L. Orci,et al. Possible Roles of the Pancreatic D-cell in the Normal and Diabetic States , 1977, Diabetes.
[19] G. Grodsky,et al. Regulation of pancreatic insulin and glucagon secretion. , 1976, Annual review of physiology.
[20] J. Halter,et al. A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. , 1976, The Journal of clinical investigation.
[21] D. Porte,et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.
[22] G. Reaven,et al. Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. , 1976, The American journal of medicine.
[23] J. Palmer,et al. Arginine-stimulated Acute Phase of Insulin and Glucagon Secretion: I. In Normal Man , 1975, Diabetes.
[24] W. Liston,et al. Dangers of Oxytocin-induced Labour to Fetuses , 1974, British medical journal.
[25] A. Barnes,et al. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose. , 1974, Lancet.
[26] C. J. Goodner,et al. Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas , 1974, Science.
[27] J. Brown,et al. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. , 1973, The Journal of clinical endocrinology and metabolism.
[28] P. Felig,et al. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. , 1973, The Journal of clinical investigation.
[29] D. Porte,et al. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. , 1973, Federation proceedings.
[30] I. Valverde,et al. Hyperglucagonism induced by glucocorticoid treatment in man. , 1973, The New England journal of medicine.
[31] D. Porte,et al. Studies of secretin-stimulated insulin responses in man. , 1972, The Journal of clinical investigation.
[32] J. Turtle. Glucose and Insulin Secretory Response Patterns Following Diet and Tolazamide Therapy in Diabetes , 1970, British medical journal.
[33] D. Porte,et al. Human insulin secretion: as integrated approach. , 1970, Annual review of medicine.
[34] D. Porte,et al. Insulin responses to glucose: evidence for a two pool system in man. , 1969, The Journal of clinical investigation.
[35] J. Beck,et al. Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. , 1969, The Journal of clinical investigation.
[36] T. Kuzuya,et al. Effects of methacholine on insulin secretion in man. , 1968, The Journal of clinical endocrinology and metabolism.
[37] C. J. Goodner,et al. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. , 1968, Annals of internal medicine.
[38] G. Reaven,et al. Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus , 1967, Diabetes.
[39] D. Porte,et al. The effect of epinephrine on immunoreactive insulin levels in man. , 1966, The Journal of clinical investigation.
[40] S. Fajans,et al. Stimulation of insulin secretion by amino acids. , 1966, The Journal of clinical investigation.
[41] D. Porte,et al. Inhibition of Insulin Release by Norepinephrine in Man , 1966, Science.
[42] V. Marks,et al. PROMOTION OF INSULIN SECRETION BY GLUCAGON. , 1965, Lancet.
[43] M. T. Brennan,et al. Failure of Prolonged Sulfonylurea Administration to Enhance Insulogenic Response to Glycemic Stimulus , 1965, Diabetes.